Vincent Rajkumar
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
Vincent Rajkumar
Jul 18, 2024, 15:14 |
Opinion
Vincent Rajkumar: Mayo Clinic continues to be the leader in US News Rankings
Vincent Rajkumar shared on X: "Mayo Clinic continues to be the leader in US News…
Jul 15, 2024, 13:51 |
Blog
Oncoinfluencers to Follow on Social Media: Dr. Vincent Rajkumar
We're excited to highlight Dr. Vincent Rajkumar, a distinguished expert in hematology/oncology, as our next…
Jul 9, 2024, 14:42 |
Drugs
Vincent Rajkumar: FDA approval doesn’t necessarily mean standard of care
Vincent Rajkumar shared on X: "FDA approval doesn’t necessarily mean standard of care. For example,…
Jul 8, 2024, 19:42 |
Insight
Vincent Rajkumar: 2024 Update on multiple myeloma
Vincent Rajkumar shared on X: “2024 update on multiple myeloma is available open access! Latest ASCO24…
Jul 6, 2024, 02:09 |
Blog
Vincent Rajkumar: We are grateful to Dr. Brian Durie for 35 years of dedication to the IMF
Vincent Rajkumar shared on X: "The International Myeloma Foundation just announced a major leadership transition. We…
Jul 2, 2024, 15:20 |
Insight
Vincent Rajkumar’s 2024 update on diagnosis, risk stratification, and treatment of myeloma
Vincent Rajkumar shared on X: “Just out: My 2024 Update on diagnosis, risk stratification, and…
Jun 30, 2024, 14:18 |
Blog
Vincent Rajkumar's 2024 AJH update on diagnosis and treatment of myeloma will be out soon
Vincent Rajkumar shared a post on X: . "My 2024…
Jun 28, 2024, 14:06 |
Blog
Vincent Rajkumar: Cure is a simple word. But there is confusion when it comes to cancer
Vincent Rajkumar shared a post on X: “Cure is a simple word. But there is…
Jun 25, 2024, 07:32 |
Blog
Vincent Rajkumar: Submit your best papers in hematologic malignancies to Blood Cancer Journal
Vincent Rajkumar shared a post on X: . “Submit your best papers in hematologic malignancies…
Jun 23, 2024, 21:03 |
Blog
Blood Cancer Journal is among the top 3 hematology journals by impact factor
Vincent Rajkumar shared a post on X: "Just out! Blood Cancer Journal Impact Factor is…
Jun 23, 2024, 13:01 |
Blog
Naveen Pemmaraju: Intersection of Multiple Myeloma and Myeloproliferative Neoplasms
Naveen Pemmaraju shared a post on X: "Intersection of multiple myeloma and Myeloproliferative Neoplasms! Joseph…
Jun 21, 2024, 14:07 |
Insight
Manni Mohyuddin: Our paper on performance of myeloma staging systems
Manni Mohyuddin shared on X/Twitter: "Our paper on performance of myeloma staging systems just out: Thanks…
Jun 19, 2024, 02:11 |
Blog
Vincent Rajkumar: International Myeloma Foundation bringing together leaders from around the world
Vincent Rajkumar shared on X: . "The International Myeloma Working Group…
Jun 13, 2024, 07:12 |
Blog
Vincent Rajkumar: 15th Annual International Myeloma Working Group summit opens in Madrid
Vincent Rajkumar shared a post on X: "15th Annual International Myeloma Working Group summit opens in…
Jun 13, 2024, 06:08 |
Blog
Rahul Banerjee: So honored to have gotten Shaji Kumar’s wisdom on so many multiple myeloma questions
Rahul Banerjee, Assistant Professor at the Fred Hutchinson Cancer Center, shared on X: "So honored to…
Jun 11, 2024, 10:23 |
Blog
Vincent Rajkumar: The priorities for what’s next in myeloma research has changed
Alexandros Alexandropoulos, Hematologist at Laiko General Hospital, shared a post by Vincent Rajkumar, on X: "Some…
Jun 11, 2024, 02:30 |
Blog
Vincent Rajkumar: With recent advances, the priorities for what is next in myeloma research has changed
Vincent Rajkumar shared a post on X: “With recent advances, the priorities for what is next…
Jun 9, 2024, 10:19 |
Opinion
Vincent Rajkumar: A friend waited in a big city emergency room for 5 hours
Vincent Rajkumar shared a post on X: "A friend with an acute scalp injury needing multiple…
Jun 7, 2024, 14:59 |
Blog
Vincent Rajkumar: ASCO24 myeloma papers that I will be highlighting
Vincent Rajkumar shared a post on X: ''First of the NEJM ASCO24 myeloma papers that I…
Jun 7, 2024, 10:36 |
Insight
Vincent Rajkumar: I’m updating my 2024 Review on myeloma for American Journal of Hematology
Vincent Rajkumar shared a post on X: “I’m updating my 2024 Review on myeloma for American…
Jun 2, 2024, 23:06 |
Blog
Vincent Rajkumar: The 4 big myeloma randomized trials to watch out for ASCO24
Vincent Rajkumar shared a post on X: "The 4 big myeloma randomized trials to watch out…
May 31, 2024, 09:24 |
Insight
Vincent Rajkumar: International Myeloma Working Group guidelines CAR-T cell treatment in myeloma by Yi Lin
Vincent Rajkumar shared on X: "Just out: International Myeloma Working Group guidelines CAR-T cell treatment…
May 29, 2024, 15:32 |
Insight
Myeloma Paper of the Day, May 29th, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: Report of a modified Staging…
May 27, 2024, 09:13 |
Insight
Vincent Rajkumar: My view on what the word Cure should mean in myeloma
Vincent Rajkumar shared a post on X: “At COMy Congress I laid out my view…
May 27, 2024, 06:35 |
Blog
Timothée Olivier: An academic study addressing a practical clinical question!
Timothée Olivier, Medical Oncologist at HUG – Geneva University Hospitals, shared a post on X:…
May 22, 2024, 00:41 |
Blog
Vincent Rajkumar: All the best healthcare is not of value if it is not accessible or affordable
Vincent Rajkumar shared a post on X: "US healthcare is in many ways the best…
May 17, 2024, 13:44 |
Drugs
Rahul Banerjee: Analysis of carfilzomib dosing in R/R myeloma
Rahul Banerjee, Assistant Professor in the Division of Medical Oncology at the University of Washington, posted…
May 7, 2024, 23:23 |
Blog
Naveen Pemmaraju: Delighted to spend some time intersecting MPNSM
Naveen Pemmaraju made the following post on X: "HOPLive24 HemOnc Pulse || Delighted to spend…
May 7, 2024, 23:15 |
Blog
Chadi Nabhan: Only at the HOPLive24 you could spot Vincent Rajkumar playing guitar while Aaron Goodman attempting to sing
Vivek Subbiah shared the following post by Chadi Nabhan, Medical Director of The University of Chicago…
May 7, 2024, 10:48 |
Blog
Vincent Rajkumar: Primary Care is essential for well being of the public and healthcare cannot be merely transactional
Vincent Rajkumar shared a post by Jason Hartley, Regional Vice President of West Region of IVX Health, on…
May 7, 2024, 02:50 |
Blog
Mikkael A. Sekeres: Look at these brilliant minds of hematology…and me
Mikkael A. Sekeres, Chief, Division of Hematology at Sylvester Comprehensive Cancer Center, shared a post…
May 3, 2024, 14:23 |
Blog
Vincent Rajkumar: International Myeloma Working Group guidelines for bispecific antibodies myeloma
Vincent Rajkumar shared a post on X: "Just out: International Myeloma Working Group guidelines for bispecific…
May 3, 2024, 05:06 |
Opinion
Vincent Rajkumar on the Importance of Accelerated Approval for Cancer Treatment
Vincent Rajkumar, Editor in Chief of Blood Cancer Journal, shared on X: "On Accelerated Approval…
Apr 29, 2024, 20:19 |
Blog
Chadi Nabhan: “Unanswered Questions” in Heme Cancers
Chadi Nabhan, Medical Director of The University of Chicago Medical Center, shared a post on X:…
Apr 26, 2024, 15:15 |
Blog
Aaron Goodman: I will be hosting the myeloma session with some legends in the field
Aaron Goodman shared a post by Chadi Nabhan, Chairman of Precision Oncology Alliance, on X/Twitter:…
Apr 25, 2024, 21:35 |
Opinion
Vincent Rajkumar: 10 suggested action items for physician colleagues
Vincent Rajkumar, Editor-in-Chief of Blood Cancer Journal, shared on X/Twitter: ''10 suggested action items for…
Apr 23, 2024, 23:38 |
Drugs
Vincent Rajkumar: All the drug approvals for relapsed multiple myeloma in 20 years
Tina Crosbie, Hematology Pharmacist at The Ottawa Hospital and at Extend Pharmacy, shared a post…
Apr 16, 2024, 20:21 |
Blog
Yelak Biru: Read the Spring Edition of "Myeloma Today," welcoming Vincent Rajkumar as our Board Chair
Yelak Biru, President and Chief Executive Officer at the International Myeloma Foundation, shared a post…
Apr 14, 2024, 04:22 |
Blog
Vincent Rajkumar: Of all my tweets on taking care of patients, here are 3 personal favorites
Vincent Rajkumar, Editor-in-Chief of Blood Cancer Journal, shared on X/Twitter: "Of all my tweets on…
Mar 30, 2024, 21:20 |
Drugs
Vincent Rajkumar: 2 years later, over 2000 drugs - at low prices
Vincent Rajkumar, Editor in Chief of Blood Cancer Journal, shared a post by Eric Feigl-Ding,…
Mar 20, 2024, 16:53 |
Insight
Vincent Rajkumar: ODAC votes 11-0 to recommend approval of Cilta-Cel in patients with relapsed/refractory multiple myeloma in earlier stages
Vincent Rajkumar, Editor in Chief of Blood Cancer Journal, shared on X/Twitter: "Breaking: ODAC votes…
Mar 20, 2024, 14:31 |
Drugs
Vincent Rajkumar: Price difference Mark Cuban Cost Plus Drug Company vs Pharmacies
Vincent Rajkumar, Professor of Medicine at the Mayo Clinic, recently shared on X/Twitter: "Price difference…
Mar 8, 2024, 23:29 |
Opinion
Vincent Rajkumar: I'm a doctor. Nothing scares me more about my future than healthcare
Vincent Rajkumar, Professor of Medicine at the Mayo Clinic, shared a post on X: "Im a…
Mar 7, 2024, 16:59 |
Insight
Vincent Rajkumar: Summary of drug approvals in relapsed myeloma
Vincent Rajkumar, Professor of Medicine at the Mayo Clinic, shared a post on X: “Summary of…
Mar 4, 2024, 10:31 |
Blog
Vincent Rajkumar: We cannot realize the true potential from CART much in current mode of approving it like a drug
Vincent Rajkumar, Professor of Medicine at the Mayo Clinic, shared a post on X/Twitter: "We cannot…
Mar 1, 2024, 18:37 |
Drugs
Vincent Rajkumar: How many years of life gained because of FDA accelerated approval in myeloma?
Vincent Rajkumar, Editor-in-Chief at the Blood Cancer Journal, shared a thread on X/Twitter: "How many…
Feb 13, 2024, 07:21 |
Blog
Vincent Rajkumar: Updated mSMART recommendations for treatment of newly diagnosed myeloma
Vincent Rajkumar, Professor of Medicine at the Mayo Clinic in Rochester, Minnesota, shared a post…
Feb 10, 2024, 19:10 |
Blog
Nishant Tiwari: A thread on my Hemeonc application
Nishant Tiwari, Internal Medicine Resident in Loyola - MacNeal Program, shared a thread on X/Twitter:…
Feb 8, 2024, 17:31 |
Blog
David Steensma: Dr. Bob Kyle's memoir, "A Physician's Journey"
David Steensma, Chief Medical Officer at Ajax Therapeutics, recently posted on X/Twitter: "The Digital Press at…
Feb 1, 2024, 14:05 |
Blog
Vincent Rajkumar: Two major studies on Essential Thrombocythemia in Blood Cancer Journal each with 1000 patients
Vincent Rajkumar, Professor of Medicine at the Mayo Clinic in Rochester, Minnesota, shared a post…
Jan 28, 2024, 04:00 |
Blog
Vincent Rajkumar: These are two incredible leaders and thinkers and they helped make my career
Vincent Rajkumar, Professor of Medicine at the Mayo Clinic in Rochester, Minnesota, shared a post…
Jan 21, 2024, 11:50 |
Blog
Vincent Rajkumar: A leader is different than a leadership title
Vincent Rajkumar, Professor of Medicine at the Mayo Clinic in Rochester, Minnesota, shared a post…
Jan 19, 2024, 19:01 |
Blog
Faheema Hasan: The myeloma guru Vincent Rajkumar giving such deep insights on WHY MYELOMA HAS NOT BEEN CURABLE?
Faheema Hasan, Assistant Professor, Department of Clinical Hematology and Stem Cell Transplant at SGPGIMS, shared…
Jan 9, 2024, 13:04 |
Blog
Vincent Rajkumar: My year end endorsements
Vincent Rajkumar, Professor of Medicine at the Mayo Clinic in Rochester, Minnesota, shared a post on…
Jan 8, 2024, 14:26 |
Blog
Vincent Rajkumar: FDA to allow Florida to import prescription drugs from Canada to combat high prices
Vincent Rajkumar, Editor-in-Chief of the Blood Cancer Journal, shared a thread on X/Twitter: "Huge news: FDA…
Jan 6, 2024, 17:03 |
Blog
Vincent Rajkumar: Important for Medicare recipients
Vincent Rajkumar, Professor of Medicine at the Mayo Clinic in Rochester, Minnesota, shared a post on…
Jan 5, 2024, 22:28 |
Blog
Vincent Rajkumar: mSMART guidelines for myeloma are now available to download as PowerPoint slides
Vincent Rajkumar, Professor of Medicine at the Mayo Clinic in Rochester, Minnesota, shared a post on…
Jan 1, 2024, 18:27 |
Blog
Vincent Rajkumar: Mayo mSMART guidelines for ATTR Amyloidosis
Vincent Rajkumar, Professor of Medicine at the Mayo Clinic in Rochester, Minnesota, shared a post…
Dec 23, 2023, 03:36 |
Blog
Vincent Rajkumar: Updated treatment approach to newly diagnosed myeloma based on new ASH 23 data
Vincent Rajkumar, Editor-in-Chief at Blood Cancer Journal, recently posted on X/Twitter: “Updated treatment approach to…
Dec 18, 2023, 13:10 |
Blog
Vincent Rajkumar: Updated treatment approach to newly diagnosed myeloma based on new ASH23 data
Vincent Rajkumar, Editor-in-Chief at Blood Cancer Journal, recently posted on X/Twitter: "Updated treatment approach to…
Dec 17, 2023, 16:40 |
Blog
Vincent Rajkumar: My head is going to explode
Vincent Rajkumar, Editor-in-Chief of the Blood Cancer Journal, shared a thread on X/Twitter: "This is…
Dec 3, 2023, 15:55 |
Stories
Vincent Rajkumar: How a patient with cancer came up with the idea for a randomized trial, and how listening to him saved a lot of lives
Vincent Rajkumar, Editor-in-Chief of the Blood Cancer Journal, shared on Twitter: "I would like to…
Nov 29, 2023, 17:40 |
Drugs
Vincent Rajkumar: Predictably Big Pharma has gone to court to fight the limited ability of Medicare to negotiate prices
Vincent Rajkumar, Editor-in-Chief of the Blood Cancer Journal, shared on X/Twitter: "Predictably Big Pharma has…
Nov 15, 2023, 16:56 |
Opinion
Vincent Rajkumar: Good leadership finds the outliers and deals with them
Vincent Rajkumar, Editor-in-Chief of the Blood Cancer Journal, shared a thread on X/Twitter: "Good leadership…
Nov 10, 2023, 18:23 |
Blog
Vincent Rajkumar: You can get great medical care in the US if you...
Vincent Rajkumar, Professor of Medicine at Mayo Clinic, shared a post on Twitter: "You can…
Nov 4, 2023, 16:12 |
Drugs
Vincent Rajkumar: How I treat newly diagnosed myeloma
Vincent Rajkumar, Editor-in-Chief of the Blood Cancer Journal, shared on Twitter: "How I treat newly…
Nov 4, 2023, 01:23 |
Drugs
Vincent Rajkumar: Pay or Die public premiere
Vincent Rajkumar, Editor-in-Chief of Blood Cancer Journal, recently posted on X/Twitter. "Pay or Die public…
Oct 29, 2023, 17:56 |
Blog
Vincent Rajkumar: When you grant a for-profit company monopoly rights to a life-saving drug, you must set a ceiling on the price to protect the public— common sense
Quoting Vincent Rajkumar, Editor-in-Chief of the Blood Cancer Journal, on X/Twitter: "When you grant a…
Oct 26, 2023, 09:18 |
Blog
Vincent Rajkumar: After 20 years since inception, we got the final completion from CIRB today
Vincent Rajkumar, Editor in Chief of Blood Cancer Journal, posted on Twitter: "I’m really proud…
Oct 19, 2023, 18:07 |
Blog
Vincent Rajkumar: The United States can save 5 to 10 billion a year on lenalidomide if it did what other countries do
Vincent Rajkumar, Professor of Medicine at the Mayo Clinic, shared a thread on X/Twitter: "The…
Oct 17, 2023, 18:11 |
Blog
Vincent Rajkumar: Lenalidomide 1 pill: $10 in Canada / $800 in USA
Vincent Rajkumar, Editor-in-Chief at Blood Cancer Journal, recently shared a post by Russell Sterrett on…
Oct 15, 2023, 18:19 |
Insight
A deep dive into MGUS in the setting of neuropathy with Manni Mohyuddin
Manni Mohyuddin, Assistant Professor in the Division of Hematology/Bone Marrow Transplant at the University of…
Oct 4, 2023, 17:10 |
Blog
Vincent Rajkumar: Amazing that Eric Feigl-Ding predicted almost 3 years ago that this research that led to mRNA Covid vaccines will win the Nobel Prize!
Vincent Rajkumar, Editor In Chief in Blood Cancer Journal, recently shared a post by Eric…
Oct 3, 2023, 18:25 |
Career
Vincent Rajkumar: My colleague Dr. Shaji Kumar at Mayo Clinic wins the Bart Barlogie Award.
Vincent Rajkumar, Editor In Chief in Blood Cancer Journal, recently shared on Twitter: "My colleague…
Sep 30, 2023, 19:37 |
Blog
Vincent Rajkumar: Dr. Nikhil Munshi has transformed Myeloma Society in his 4-year term as President.
Vincent Rajkumar, Oncologist at Mayo Clinic in Rochester, Minnesota, recently shared on Twitter: "Dr. Nikhil…
Sep 16, 2023, 17:55 |
Blog
Vincent Rajkumar: Introducing a one-stop site to estimate risk of progression in myeloma.
Vincent Rajkumar, Editor-in-Chief at Blood Cancer Journal, recently shared on X/Twitter: "MyelomaRisk.com Introducing a one-stop…
Aug 18, 2023, 07:31 |
Societies
Potential Turning Point: Is the End of ABIM MOC on ASCO's Agenda?
As discussions on ending the ABIM MOC (American Board of Internal Medicine, Maintenance of Certification)…
Aug 16, 2023, 19:41 |
Blog
Vincent Rajkumar: My interview with American Society of Hematology Clinical News may be of help to trainees.
Quoting Vincent Rajkumar,Professor of Medicine at the Mayo Clinic in Rochester, Minnesota, on Twitter: "My…
Aug 3, 2023, 11:56 |
Blog
Top 10 reasons why ABIM MOC should be abolished - Vincent Rajkumar
Top 10 reasons why ABIM MOC should be abolished. 1. It has turned an MD…
Jul 23, 2023, 17:26 |
Drugs
Myeloma drugs - Dosing and schedule by Vincent Rajkumar on Twitter
Myeloma drugs — Dosing and schedule What I do in practice Dex: 40 mg…
Jul 22, 2023, 02:37 |
Career
Vincent Rajkumar appointed as the Chair-elect of the Board of the International Myeloma Foundation
According to the International Myeloma Foundation on Twitter, "World-Renowned Scientist, S. Vincent Rajkumar, MD, Appointed…
Jul 6, 2023, 04:30 |
Insight
A collection of clincally important insights in myeloma and MGUS - Vincent Rajkumar
1/ Serum protein electrophoresis may underestimate the true size of the M protein when the…
Jun 12, 2023, 02:38 |
Societies
The International Myeloma Working Group Meeting just concluded- Vincent Rajkumar
The International Myeloma Working Group Meeting just concluded. The collaborations and camaraderie among myeloma researchers…
All:
83
Posts:
1 - 100
The largest philanthropic partnership in The V Foundation’s history - Dolphins Cancer Challenge
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
OncoDaily Party and Yvonne Award Photos - Part 1
Michael Douglas: The Untold Story of His Battle Against Cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube